Stock listing
NASDAQ:ALLO Allogene Therapeutics, Inc. Stock
Home listing (NASDAQ) of Allogene Therapeutics, Inc.
Follow Allogene Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ALLO
$1.18 USD -0.07 (-5.6%)
Close on Oct 30, 2026
- Day range
- $1.16 – $1.26 USDOct 30, 2026
- Volume
- 9.76M sharesOct 30, 2026
- Market cap
- $407.7M USDAt the close on Oct 30, 2026 · price × 345.5M shares outstanding
- 52-week range
- $1.04 – $4.46 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $10.00M USDMedian day 5.02M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALLO · Home | $1.18 USD | -0.07 (-5.6%) | 9,758,925 | $1.24 | $1.258 | $1.16 | $1.25 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ALLO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.18 | -0.07 | -5.6% | $1.24 | $1.258 | $1.16 | 9,758,925 | |
| $1.25 | -0.05 | -3.8% | $1.33 | $1.38 | $1.25 | 7,714,051 | |
| $1.30 | +0.07 | +5.7% | $1.22 | $1.335 | $1.21 | 10,323,337 | |
| $1.23 | +0.02 | +1.7% | $1.21 | $1.26 | $1.17 | 16,102,778 | |
| $1.21 | -0.04 | -3.2% | $1.26 | $1.27 | $1.19 | 10,576,283 | |
| $1.25 | 0.00 | 0.0% | $1.23 | $1.255 | $1.16 | 8,404,820 | |
| $1.25 | -0.08 | -6.0% | $1.32 | $1.33 | $1.22 | 8,296,399 | |
| $1.33 | 0.00 | 0.0% | $1.33 | $1.365 | $1.31 | 4,742,434 | |
| $1.33 | +0.03 | +2.3% | $1.30 | $1.35 | $1.29 | 4,579,577 | |
| $1.30 | -0.01 | -0.8% | $1.30 | $1.33 | $1.26 | 5,906,271 | |
| $1.31 | -0.03 | -2.2% | $1.34 | $1.34 | $1.29 | 4,919,065 | |
| $1.34 | +0.04 | +3.1% | $1.33 | $1.37 | $1.30 | 4,515,192 | |
| $1.30 | +0.01 | +0.8% | $1.28 | $1.308 | $1.22 | 7,736,868 | |
| $1.29 | -0.11 | -7.9% | $1.39 | $1.395 | $1.29 | 6,543,528 | |
| $1.40 | -0.06 | -4.1% | $1.45 | $1.46 | $1.39 | 4,316,472 | |
| $1.46 | +0.06 | +4.3% | $1.39 | $1.48 | $1.37 | 10,605,410 | |
| $1.40 | -0.03 | -2.1% | $1.44 | $1.44 | $1.345 | 7,983,952 | |
| $1.43 | -0.03 | -2.1% | $1.46 | $1.47 | $1.42 | 3,899,722 | |
| $1.46 | -0.04 | -2.7% | $1.50 | $1.50 | $1.43 | 4,659,678 | |
| $1.50 | 0.00 | 0.0% | $1.495 | $1.52 | $1.45 | 4,443,265 | |
| $1.50 | -0.04 | -2.6% | $1.57 | $1.579 | $1.50 | 4,656,621 | |
| $1.54 | -0.06 | -3.8% | $1.60 | $1.61 | $1.53 | 4,606,898 | |
| $1.60 | -0.02 | -1.2% | $1.61 | $1.66 | $1.58 | 8,132,422 | |
| $1.62 | -0.01 | -0.6% | $1.60 | $1.645 | $1.60 | 4,318,917 | |
| $1.63 | -0.02 | -1.2% | $1.65 | $1.665 | $1.60 | 5,026,155 | |
| $1.65 | -0.02 | -1.2% | $1.69 | $1.695 | $1.63 | 3,622,349 | |
| $1.67 | 0.00 | 0.0% | $1.67 | $1.72 | $1.60 | 7,791,092 | |
| $1.67 | -0.04 | -2.3% | $1.73 | $1.74 | $1.65 | 5,965,945 | |
| $1.71 | +0.02 | +1.2% | $1.72 | $1.74 | $1.683 | 5,237,474 | |
| $1.69 | 0.00 | 0.0% | $1.71 | $1.72 | $1.645 | 5,992,401 | |
| $1.69 | -0.04 | -2.3% | $1.73 | $1.74 | $1.67 | 12,716,960 | |
| $1.73 | +0.04 | +2.4% | $1.74 | $1.765 | $1.70 | 3,948,057 | |
| $1.69 | -0.03 | -1.7% | $1.74 | $1.77 | $1.66 | 5,648,084 | |
| $1.72 | -0.06 | -3.4% | $1.80 | $1.80 | $1.71 | 3,138,618 | |
| $1.78 | 0.00 | 0.0% | $1.775 | $1.84 | $1.765 | 7,750,773 | |
| $1.78 | +0.02 | +1.1% | $1.80 | $1.805 | $1.754 | 3,894,350 | |
| $1.76 | +0.03 | +1.7% | $1.73 | $1.78 | $1.695 | 5,401,051 | |
| $1.73 | -0.13 | -7.0% | $1.85 | $1.875 | $1.72 | 7,284,015 | |
| $1.86 | -0.11 | -5.6% | $1.93 | $1.94 | $1.85 | 7,434,268 | |
| $1.97 | -0.01 | -0.5% | $1.97 | $2.01 | $1.95 | 4,428,567 | |
| $1.98 | 0.00 | 0.0% | $2.00 | $2.01 | $1.92 | 4,425,096 | |
| $1.98 | -0.005 | -0.3% | $1.97 | $2.04 | $1.91 | 5,393,709 | |
| $1.985 | -0.015 | -0.7% | $1.96 | $1.999 | $1.93 | 4,037,910 | |
| $2.00 | -0.02 | -1.0% | $2.01 | $2.02 | $1.955 | 4,376,900 | |
| $2.02 | -0.07 | -3.3% | $2.08 | $2.09 | $2.00 | 3,824,689 | |
| $2.09 | +0.05 | +2.5% | $2.04 | $2.14 | $2.00 | 4,982,882 | |
| $2.04 | -0.13 | -6.0% | $2.17 | $2.18 | $2.03 | 5,020,715 | |
| $2.17 | +0.14 | +6.9% | $2.05 | $2.21 | $2.05 | 6,156,769 | |
| $2.03 | -0.06 | -2.9% | $2.11 | $2.11 | $2.00 | 4,755,951 | |
| $2.09 | -0.01 | -0.5% | $2.12 | $2.15 | $2.06 | 4,372,792 | |
| $2.10 | -0.13 | -5.8% | $2.19 | $2.21 | $2.07 | 4,861,236 | |
| $2.23 | +0.20 | +9.9% | $2.08 | $2.23 | $2.08 | 6,714,917 | |
| $2.03 | -0.05 | -2.4% | $2.07 | $2.085 | $2.00 | 4,088,803 | |
| $2.08 | +0.03 | +1.5% | $2.05 | $2.10 | $2.02 | 4,676,700 | |
| $2.05 | +0.07 | +3.5% | $1.96 | $2.08 | $1.92 | 4,605,146 | |
| $1.98 | -0.09 | -4.3% | $2.13 | $2.16 | $1.955 | 6,335,870 | |
| $2.07 | -0.05 | -2.4% | $2.13 | $2.145 | $2.045 | 4,577,716 | |
| $2.12 | +0.02 | +1.0% | $2.11 | $2.19 | $2.065 | 4,967,298 | |
| $2.10 | +0.09 | +4.5% | $1.99 | $2.10 | $1.978 | 5,360,498 | |
| $2.01 | +0.04 | +2.0% | $1.98 | $2.025 | $1.959 | 3,699,201 | |
| $1.97 | +0.02 | +1.0% | $1.95 | $1.99 | $1.92 | 3,170,439 | |
| $1.95 | +0.05 | +2.6% | $1.90 | $1.98 | $1.90 | 5,056,052 | |
| $1.90 | +0.06 | +3.3% | $1.87 | $1.91 | $1.82 | 4,997,390 | |
| $1.84 | -0.04 | -2.1% | $1.87 | $1.90 | $1.81 | 7,039,922 | |
| $1.88 | -0.09 | -4.6% | $1.97 | $2.00 | $1.86 | 5,521,843 | |
| $1.97 | +0.16 | +8.8% | $1.86 | $2.00 | $1.855 | 10,523,180 |
- Ticker
- NASDAQ:ALLO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data
Latest earnings call · Aug 12, 2026
Allogene Therapeutics (NASDAQ:ALLO) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 12, 2026
Q2 2026 Earnings Presentation
Earnings · 36 slides
Calls
Upcoming
Allogene Therapeutics (NASDAQ:ALLO) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 5:00 PM ET
Register
Replays
Allogene Therapeutics (NASDAQ:ALLO) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 5:00 PM ET
Watch TranscriptAllogene Therapeutics (NASDAQ:ALLO) Q1 2026 Earnings Call
Wed, May 13, 2026 · 5:00 PM ET
Watch TranscriptAllogene Therapeutics (NASDAQ:ALLO) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data
Oct 29, 2026
Closed $1.25 (-3.8%) on Oct 29, 2026
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Oct 26, 2026
Closed $1.21 (-3.2%) on Oct 26, 2026
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
Sep 2, 2026
Closed $1.98 (-0.3%) on Sep 2, 2026
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
Aug 12, 2026
Closed $1.98 (-4.3%) on Aug 13, 2026
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
Aug 4, 2026
Closed $1.90 (+3.3%) on Aug 4, 2026
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
Jul 29, 2026
Closed $1.81 (+9.0%) on Jul 29, 2026
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
Jul 15, 2026
Closed $1.90 (+2.7%) on Jul 15, 2026
Allogene Therapeutics Announces Planned CEO Succession
May 28, 2026
Closed $2.17 (-3.6%) on May 29, 2026
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
May 13, 2026
Closed $2.14 (-8.2%) on May 14, 2026
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
Apr 21, 2026
Closed $2.32 (-4.1%) on Apr 21, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 36 slides · Aug 12, 2026
Q4 2025 Earnings Presentation
Earnings · 26 slides · Mar 12, 2026
Fact Sheet (September 2025)
Fact sheet · 2 slides · September 2025
ASCO 2025
Conference · 16 slides · June 2025
Allogene Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 182 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 22 calls with a replay · 22 with a transcript · latest Aug 12, 2026
- Decks
- 12 decks · latest Aug 12, 2026
Where Allogene Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALLO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ALLO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Allogene Therapeutics, Inc.